Differential control of type-I iodothyronine deiodinase expression by the activation of the cyclic AMP and phosphoinositol signalling pathways in cultured human thyrocytes.
The effects of TSH and the activation of the cyclic AMP (cAMP) and Ca(2+)-phosphatidylinositol (Ca(2+)-PI) cascades on the activity and expression of the selenoenzyme thyroidal type-I iodothyronine deiodinase (ID-I) have been studied using human thyrocytes grown in primary culture. Stimulation of ID-I activity and expression was obtained with TSH and an analogue of cAMP, 8-bromo-cAMP. In the presence or absence of TSH, the addition of the phorbol ester, phorbol 12-myristate 13-acetate (PMA) together with the calcium ionophore A23187, caused a decrease in ID-I activity; a decrease in ID-I expression was also observed as assessed by cell labelling with [75Se]selenite. PMA alone had no effect on ID-I activity in the presence or absence of TSH. A23187 alone produced a small but significant reduction in ID-I activity, but only in TSH-stimulated cells. These data provide evidence that the expression of thyroidal ID-I is negatively regulated by the Ca(2+)-PI cascade, and positively regulated by the cAMP cascade.
Beech
S G
SG
University Department of Clinical Biochemistry, Royal Infirmary, Edinburgh, UK.
Walker
S W
SW
Arthur
J R
JR
Lee
D
D
Beckett
G J
GJ
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002277:Carcinoma / Q000473:pathology; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000502:physiology*; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004790:Enzyme Induction / Q000187:drug effects; D006111:Graves Disease / Q000473:pathology; D006801:Humans; D007453:Iodide Peroxidase / Q000096:biosynthesis* / Q000235:genetics; D008862:Microsomes, Liver / Q000378:metabolism; D010716:Phosphatidylinositols / Q000502:physiology*; D011506:Proteins / Q000378:metabolism; D051140:Selenoproteins; D015398:Signal Transduction / Q000187:drug effects*; D018038:Sodium Selenite / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013961:Thyroid Gland / Q000187:drug effects / Q000201:enzymology*; D013964:Thyroid Neoplasms / Q000473:pathology; D016606:Thyroid Nodule / Q000473:pathology; D013972:Thyrotropin / Q000494:pharmacology*
D010716:Phosphatidylinositols; D011506:Proteins; D051140:Selenoproteins; D015124:8-Bromo Cyclic Adenosine Monophosphate; D000001:Calcimycin; D013972:Thyrotropin; D000242:Cyclic AMP; D007453:Iodide Peroxidase; D018038:Sodium Selenite; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium; D004121:Dimethyl Sulfoxide